New pharma cartoner Sigpack TTMP from Bosch
Highest product protection and maximum flexibility.
Bosch Packaging Technology has added a new topload cartoner to its well-known TTM product portfolio. “The Sigpack TTMP enhances our product portfolio with an efficient and highly flexible cartoning solution, especially for pharmaceutical customers. It is based on our successful TTM platform, which is already used around the world,” explains Michael Haas, product manager at Bosch Packaging Systems.
Specifically for the pharmaceutical industry
The proven features of the TTM platform have been advanced specifically for the packaging of ampoules, vials, syringes, pens and further products from the pharmaceutical industry. A simple and safe changeover concept, high process safety and a broad format and product flexibility characterize the machine. Due to its modular design, the machine layout can be adjusted to different product infeeds. With an output of 30 up to 200 cartons, the TTMP provides individual solutions for both small and large production batches.
The Sigpack TTMP can be seamlessly combined with the Sigpack TTMC case packer. This offers customers a uniform, user-friendly operating concept for the entire line.
Great flexibility and smooth handling
Thanks to the patented format changeover concept, tool-less format changes with vertical restart can be carried out within a few minutes. The open and easily accessible machine design provides for a very fast line clearance. “The patented changeover concept enables our customers to flexibly and quickly package various pack styles on one machine. This is especially important for increasingly small batch sizes,” Haas says.
A wide range of product infeed solutions and loading possibilities ensure the gentle handling of sensitive products such as vials, ampoules, syringes and injection pens. Various gripper technologies provide for smooth packaging of the products. Depending on requirements, different mechanic, vacuum-based or grippers with airflow technology are being used. Modules for forming and inserting partitioners, package inserts and tray denesting can also be integrated.
Maximum efficiency and 100% process safety
The Sigpack TTMP is easily accessible and open. The compact, GMP-compliant design supports process safety. Additional Track & Trace-solutions such as the CPS module (Carton Printing System) from Bosch or third-party suppliers can be easily integrated. The machine can also be equipped with the Bosch CPI software, which manages serialization from the allocation of serial numbers through to the last aggregation step. Thus, the Sigpack TTMP fulfils the most recent serialization requirements for pharmaceutical products.
Various monitoring functions inspect the packaging process at several points. For instance, the carton blanks are already scanned at the infeed. Vision systems and code verification allow to examine carton contents, the correct infeed of the package inserts, as well as the intact shape of the cartons. Incorrect packs are automatically dispatched from the system by discharging devices. This concept ensures 100% process control and also speeds up line clearance during batch change.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance